about diaTribe
diaTribe Advisory Board
Dr. Richard M. Bergenstal, MD, executive director of the International Diabetes Center, is an endocrinologist at Park Nicollet Clinic in Minneapolis. He did his medical and endocrine training at the University of Chicago, and has served as a principal investigator in key research studies in type 1 and type 2 diabetes, particularly related to preventing the complications of diabetes. In 2007, he received the ADA's Outstanding Physician Clinician in Diabetes award, among the highest honors in diabetes. He is the president-elect of the American Diabetes Association.
Jennifer Block, RN, CDE is a certified diabetes educator working in pediatric endocrinology at Stanford University. She is currently doing research on the artificial pancreas. Jennifer has type 1 diabetes.
Dr. Zachary Bloomgarden, MD is a professor of medicine at the Mount Sinai School of Medicine in New York City and editor in chief of the Journal of Diabetes. He has contributed to over 150 publications in diabetes-related research and is particularly known for his "Perspectives on the News," a column on new diabetes research findings in Diabetes Care every month.
Dr. Bruce Bode, MD, FACE is a diabetes specialist with Atlanta Diabetes Associates in Atlanta, Georgia. He is very well known for his large, thriving insulin pump practice and his research in this field.
Dr. Nancy Bohannon, MD is a San Francisco-based endocrinologist who specializes in new diabetes drugs and technology in her research and private practice.
Dr. Bruce Buckingham, MD is a professor of pediatrics and endocrinology at Stanford University. He is known for his research with DirecNET in particular and his research on continuous monitoring and the artificial pancreas.
Dr. John Buse, MD, PhD, is a professor at the University of North Carolina School of Medicine in Chapel Hill, North Carolina. He serves as the Chief of the Division of Endocrinology, Director of the Diabetes Care Center, and Executive Associate Dean for Clinical Research. Dr. Buse has extensively researched type 1 and type 2 diabetes, including involvement with the ACCORD (Action to Control CardiOvascular Risk in Diabetes), STOPP-T2D (Studies to Treat Or Prevent Pediatric Type 2 Diabetes), NAVIGATOR, ORIGIN, IRIS, TECOS, FREEDOM and NASH CRN trials. Dr. Buse recently concluded his term as President, Medicine & Science at the American Diabetes Association. He has received a number of awards, including recognition as one of the Best Doctors in America since 2001.
Dr. Wayman W. Cheatham, MD, FACE is the Special Assistant to the Surgeon General for Clinical Research & Director, Clinical Investigation Programs, Bureau of Medicine & Surgery, United States Navy. He previously served as the Medical Director of MedStar Clinical Research Centers in Washington, D.C., where he was responsible for many large clinical trials in the areas of diabetes and obesity. Dr. Cheatham has extensive experience in drug development and brings to his work a deep patient understanding as he has type 2 diabetes.
Dr. Steve Edelman, MD is a professor of Medicine in the Division of Endocrinology and Metabolism at the University of California, San Diego. He is Director of the Diabetes Care Clinic at the Veterans Affairs Medical Center in San Diego as well as the founder and director of Taking Control of Your Diabetes (TCOYD). In 2009, he was named Educator of the Year at the American Diabetes Association Scientific Sessions.
Dr. Satish K. Garg, MD is a Professor of Medicine and Pediatrics at the Adult Clinic of the Barbara Davis Center for Diabetes of the University of Colorado in Denver, Colorado and the Editor-In-Chief of Diabetes Technology and Therapeutics Journal. He is a prolific researcher with over 170 original manuscripts in peer-review journals and is considered a leading expert in early detection of diabetes, treatment of renal and retinal complications of type 1 diabetes, and multiple diagnostic and therapeutic tools and therapies, including insulin analogs and glucose sensors in particular.
Dr. Barry H. Ginsberg, MD, PhD is the CEO of Diabetes Technology Consultants and a former vice president in the diabetes division at BD. He is an expert in blood glucose monitoring and drug delivery.
Jeff Halpern is a strategic consumer marketer with over 20 years of experience in marketing consumer packaged goods, high technology, and medical devices. Most recently, Jeff managed the Glad Food Storage brand at The Clorox Company. Jeff has type 1 diabetes.
Dr. Lutz Heinemann, MD is the CEO of Profil Institute for Metabolic Research in Neuss, Germany. He is involved in numerous studies with patients with type 1 and type 2 diabetes and is viewed as an expert in diabetes technology in particular.
Debbie Hinnen, MN, ARNP, BC-ADM, CDE, FAAN is a noted diabetes educator from Kansas with the Mid-America Diabetes Associates. She has served as the president of the American Association of Diabetes Educators and is involved with much new product development.
Dr. Irl Hirsch, MD is a professor of medicine in the division of Metabolism, Endocrinology, and Nutrition at the University of Washington. He is well known for his research on insulin and glycemic variability, among other topics. Dr. Hirsch has type 1 diabetes.
Jeff Hitchcock is the founder of Children with Diabetes, one of the largest diabetes-related web sites in the world. He is particularly inspired by his daughter Marissa, who has type 1 diabetes, and is currently studying to be a Certified Diabetes Educator.
Dr. Lois Jovanovic, MD, FACE is the Director of the Sansum Diabetes Research Institute in Santa Barbara, California. Her research has focused on pregnancy and diabetes and she is widely considered the foremost expert in the world on this topic. Dr. Jovanovic has type 1 diabetes.
Dr. Francine Kaufman, MD is the head of the Division of Endocrinology and Metabolism at the Children's Hospital in Los Angeles and a pediatric endocrinologist at the University of Southern California. She is a former president of the American Diabetes Association and the medical director at a summer camp for children with diabetes.
David M. Kendall, MD is the Chief Scientific and Medical Officer of the American Diabetes Association. Prior to his appointment to the ADA, he was the Medical Director and Chief of Clinical and Professional Services at the International Diabetes Center in Minneapolis, MN. An active diabetes researcher, educator and clinician, Dr. Kendall has both clinical and laboratory based research interests. His clinical studies focus on the prevention and treatment of cardiovascular complications of diabetes while his laboratory research centers on emerging treatments for diabetes, insulin resistance, and the metabolic syndrome. He is particularly well known for his research on emerging incretin-based therapies for type 2 diabetes.
Dr. Aaron Kowalski, PhD is the Director of Strategic Research Projects of the Juvenile Diabetes Research Fund, an organization dedicated to finding a cure for diabetes. He leads the efforts of the Artificial Pancreas Project at JDRF. Dr. Kowalski has type 1 diabetes.
Dr. Harold Lebovitz, MD is Professor of Medicine in the Division of Endocrinology and Metabolism at the State University of New York (SUNY) Health Science Center at Brooklyn. He has served on numerous review committees for the American Diabetes Association, the National Institutes of Health, and the Veterans Administration, and serves on the editorial boards of Diabetes, Obesity and Metabolism, and Diabetes Care.
Linda Parks RN, CDE is a certified diabetes educator at Marin General Hospital in San Rafael, California, educating both patients and staff on diabetes management and care. She has over 20 years experience working in clinical care in a variety of settings, as well as having held a number of clinical positions within industry at medical device companies. She has special interest and expertise in continuous glucose monitoring, diabetes in the schools, and inpatient diabetes management.
Dr. William H. Polonsky, PhD, CDE is a professor of psychiatry at the University of California San Diego and the founder of the Behavioral Diabetes Institute, an organization focusing on the psychological aspects of diabetes.
Michael Robinton is the founder and Executive Director of Insulin Pumpers (www.insulin-pumpers.org), a large online forum for pump users.
Francesco Rubino, MD is the Chief of Gastrointestinal Metabolic Surgery, an Associate Professor of Surgery, and an Associate Attending Surgeon at New York-Presbyterian/Weill Cornell Medical Center. Dr. Rubino is a pioneer in the emerging field of surgery for type 2 diabetes. He leads the Diabetes Surgery Center at the New York-Presbyterian/Weill Cornell Medical Center, the first academic-based diabetes surgery center in the United States, and is considered the leading expert in surgery for type 2 diabetes. Dr. Rubino is the author of more than 70 articles in peer-reviewed journals and 20 book chapters.
Jane Jeffrie Seley, NP, CDE is a nurse practitioner and diabetes educator on the Diabetes Team at New York Presbyterian-Weill Cornell Medical Center in New York City. She holds several leadership roles in the New York City chapters of ADA and AADE.
Dr. Jay Skyler, MD is Professor, Division of Endocrinology, Diabetes, and Metabolism and Associate Director of the Diabetes Research Institute at the University of Miami Miller School of Medicine. Dr. Skyler's research interests are in the clinical aspects of diabetes, particularly improving the care of type 1 diabetes through glycemic control, psychosocial and behavioral support, immune intervention and beta cell expansion. He is a past President of the American Diabetes Association.
Howard Steinberg is founder/CEO of LifeMed Media Inc. (LMM), the parent company of dLife. Prior to launching LMM/dLife, Mr. Steinberg founded Source Marketing, a nationally recognized leader in marketing services. In 1998, Mr. Steinberg sold Source Marketing to MDC Partners, the largest advertising company in Canada and continued operating as CEO. Prior to Source, Steinberg served in roles of increasing marketing responsibility at Pepsi Cola Co. Mr. Steinberg has lived with type 1 diabetes since age 10, and as a young adult aggressively took charge of his condition. He is an author of children’s books about diabetes and serves on various non-profit boards including diaTribe.
Dr. Paul Strumph, MD is the former Chief Medical Officer of the Juvenile Diabetes Research Foundation. He has substantial experience stemming from his six years of pediatric endocrinology clinical practice, and nearly a decade of experience working in drug development in the private sector. He currently serves as the Chief Medical Officer for Sensors for Medicine and Science, Inc.
Virginia Valentine, CNS, BC-ADM, CDE is the CEO of Diabetes Network in New Mexico and the 2006 recipient of the American Association of Diabetes Educators Distinguished Service Award. Virginia has type 2 diabetes.
Dr. Howard Wolpert, MD is the director of the Insulin Pump Program and a clinical investigator at the Joslin Diabetes Center in Boston as well as an instructor of medicine at Harvard Medical School.
Mark Yarchoan is a medical student at the University of Pennsylvania with an interest in diabetes care and metabolic disease. He has been a long-standing contributor and editor of diaTribe and has reported on numerous diabetes and obesity conferences.
Gloria Yee, RN, CDE is a certified diabetes educator at the Diabetes Teaching Center at the University of California San Francisco. Her research focuses on diabetes technology. Gloria has type 1 diabetes.
Professor Paul Zimmet, MD is a Professor of Medicine at Monash University and a director at the International Diabetes Institute both in Melbourne, Australia. The "Endo of Oz" is also co-Chair of the IDF Task Force on Epidemiology. He also serves on the Australian Government's Strategic Taskforce on Diabetes.
Dr. Bernie Zinman, MD is the Director of the Leadership Sinai Center for Diabetes at Mount Sinai Hospital and the University of Toronto, Canada, where he is also a Professor of Medicine. His main research interests include the long-term complications of diabetes, the development of new therapies for type 1 and type 2 diabetes, diabetes in Aboriginal communities, and studies directed at the prevention of diabetes.
Dr. Howard Zisser, MD is the Director of Clinical Research and Diabetes Technology at Sansum Diabetes Research Institute in Santa Barbara, California and serves Adjunct Professor of Chemical Engineering at the University of California, Santa Barbara. His research interests focus on the testing of new drugs and devices to treat diabetes. He has directed numerous clinical trials and investigator-initiated studies involving type 1, type 2, and gestational diabetes, including pivotal testing of implanted glucose sensors, implanted insulin pumps, inhaled insulin, oral insulin, and continuous glucose sensing in pregnancy.